SRINIVAS AKKARAJU Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SRINIVAS AKKARAJU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SRINIVAS AKKARAJU. SRINIVAS AKKARAJU is a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a Director in aTYR PHARMA INC ($LIFE) and a Director in ADURO BIOTECH, INC. ($ADRO) and a Director in ZS Pharma, Inc. ($ZSPH) and a Director in Principia Biopharma Inc. ($PRNB) and a Director in Versartis, Inc. ($VSAR) and a Director in Syros Pharmaceuticals, Inc. ($SYRS) and a Director in Jiya Acquisition Corp. ($JYAC).
Companies in which SRINIVAS AKKARAJU is an Insider
Aravive, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 576,066 shares
Current Value: $7,661,678
Latest Transaction: Dec 02 2019
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
aTYR PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SRINIVAS AKKARAJU: Director
Holdings: 1,866,126 shares
Current Value: $6,344,828
Latest Transaction: May 11 2017
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CHINOOK THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 3,168,388 shares
Current Value: $35,485,946
Latest Transaction: Jun 08 2021
$ADRO Market Capitalization: $745.72M
$ADRO Previous Close: $11.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INTERCEPT PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 477,129 shares
Current Value: $54,187,541
Latest Transaction: Mar 12 2021
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jiya Acquisition Corp.
Industry: BLANK CHECKS [6770]
Position of SRINIVAS AKKARAJU: Director
Holdings: 507,041 shares
Latest Transaction: Apr 15 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Principia Biopharma Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 208,480 shares
Latest Transaction: Jan 10 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SRINIVAS AKKARAJU: Director
Holdings: 41,503 shares
Current Value: $2,522,967
Latest Transaction: May 19 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 1,899,616 shares
Current Value: $20,743,807
Latest Transaction: Dec 11 2020
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ZS Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 0 shares
Latest Transaction: Dec 21 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of SRINIVAS AKKARAJU
Sentiment: All, ARAV, LIFE, ADRO, ICPT, JYAC, PRNB, SGEN, SYRS, ZSPH
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2021 | ADRO | CHINOOK THERAPEUTI ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 16.81 | 5,948 | 99,986 | 5,948 | |
| Apr 15 2021 | JYAC | Jiya Acquisition C ... | AKKARAJU SRINIVAS | Director | Option Exercise | J | 0.00 | 5,000 | 0 | 2,412,447 | |
| Mar 12 2021 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | P | 21.29 | 147,000 | 3,129,630 | 640,688 | 493.7 K to 640.7 K (+29.78 %) |
| Mar 12 2021 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | P | 21.55 | 16,559 | 356,846 | 493,688 | 477.1 K to 493.7 K (+3.47 %) |
| Mar 12 2021 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | P | 20.83 | 73,441 | 1,529,776 | 477,129 | 403.7 K to 477.1 K (+18.19 %) |
| Dec 11 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 11.00 | 156,250 | 1,718,750 | 156,250 | |
| Dec 11 2020 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 625,000 | 0 | 1,899,616 | 1.3 M to 1.9 M (+49.03 %) |